We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $27B
1-Year Est. Return 24.49%
This Fund
S&P 500
This Quarter Est. Return
+21.7%
1 Year Est. Return
+24.49%
3 Year Est. Return
+88.53%
5 Year Est. Return
+114.58%
10 Year Est. Return
+419.26%
AUM
$10.9B
AUM Growth
+$1.89B
Cap. Flow
+$164M
Cap. Flow %
1.51%
Top 10 Hldgs %
21.79%
Holding
2,159
New
88
Increased
943
Reduced
632
Closed
97

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.4M
2
META icon
Meta Platforms (Facebook)
META
+$13.8M
3
ABBV icon
AbbVie
ABBV
+$10.8M
4
AMZN icon
Amazon
AMZN
+$10.7M
5
GILD icon
Gilead Sciences
GILD
+$9.53M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$18.9M
2
RTN
Raytheon Company
RTN
+$12.4M
3
CB icon
Chubb
CB
+$5.57M
4
MSFT icon
Microsoft
MSFT
+$5.33M
5
PG icon
Procter & Gamble
PG
+$5.19M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 15.34%
3 Financials 12.17%
4 Consumer Discretionary 8.84%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRFT
1776
DELISTED
Perficient Inc
PRFT
$20K ﹤0.01%
550
+50
+10% +$1.66K
DRNA
1777
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$20K ﹤0.01%
775
+225
+41% +$4.85K
AHT
1778
Ashford Hospitality Trust
AHT
$21M
$19K ﹤0.01%
26
ALRM icon
1779
Alarm.com
ALRM
$2.85B
$19K ﹤0.01%
300
ATI icon
1780
ATI
ATI
$31B
$19K ﹤0.01%
1,855
+625
+51% +$5.42K
CBT icon
1781
Cabot Corp
CBT
$4.52B
$19K ﹤0.01%
500
CLF icon
1782
Cleveland-Cliffs
CLF
$6.99B
$19K ﹤0.01%
3,510
+614
+21% +$2.99K
FATE icon
1783
Fate Therapeutics
FATE
$326M
$19K ﹤0.01%
555
+30
+6% +$894
OVV icon
1784
Ovintiv
OVV
$16.4B
$19K ﹤0.01%
+2,020
New +$14.1K
PDLB icon
1785
Ponce Financial Group
PDLB
$485M
$19K ﹤0.01%
+2,651
New +$17.4K
RMBS icon
1786
Rambus
RMBS
$11B
$19K ﹤0.01%
1,250
-270
-18% -$3.8K
VIR icon
1787
Vir Biotechnology
VIR
$1.49B
$19K ﹤0.01%
460
+360
+360% +$12.1K
BEAT
1788
DELISTED
BioTelemetry, Inc.
BEAT
$19K ﹤0.01%
415
+190
+84% +$8.51K
AMKR icon
1789
Amkor Technology
AMKR
$13.7B
$18K ﹤0.01%
1,425
+505
+55% +$5.21K
APLS
1790
DELISTED
Apellis Pharmaceuticals
APLS
$18K ﹤0.01%
550
BANC icon
1791
Banc of California
BANC
$2.97B
$18K ﹤0.01%
1,620
BBIO icon
1792
BridgeBio Pharma
BBIO
$16.5B
$18K ﹤0.01%
550
CMRE icon
1793
Costamare
CMRE
$1.77B
$18K ﹤0.01%
3,150
DHIL
1794
DELISTED
Diamond Hill
DHIL
$18K ﹤0.01%
155
-25
-14% -$2.62K
DNLI icon
1795
Denali Therapeutics
DNLI
$3.97B
$18K ﹤0.01%
760
+300
+65% +$7.05K
KOD icon
1796
Kodiak Sciences
KOD
$2.84B
$18K ﹤0.01%
335
+95
+40% +$5.36K
MTSI icon
1797
MACOM Technology Solutions
MTSI
$23.7B
$18K ﹤0.01%
535
+45
+9% +$1.31K
MWA icon
1798
Mueller Water Products
MWA
$4.16B
$18K ﹤0.01%
1,860
+290
+18% +$2.6K
NKSH icon
1799
National Bankshares
NKSH
$268M
$18K ﹤0.01%
615
+145
+31% +$4.22K
OSBC icon
1800
Old Second Bancorp
OSBC
$1.29B
$18K ﹤0.01%
2,275
+145
+7% +$1.07K

Similar funds

Nisa Investment Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Nisa Investment Advisors held 2,159 positions worth $10.9B, up 21% from $8.98B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nisa Investment Advisors's Q2 2020 filing shows 88 new, 943 increased, 632 reduced and 97 closed positions. Its largest new stake was Otis Worldwide: 129,485 shares worth $7.36M. The largest sale was Allergan plc, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Nisa Investment Advisors's largest Q2 2020 buy was Otis Worldwide: 129,485 shares worth $7.36M.
  • Nisa Investment Advisors added most to Apple in Q2 2020, an estimated $14.4M increase.
  • Nisa Investment Advisors's biggest Q2 2020 reduction was Chubb, cutting an estimated $5.57M.
  • Nisa Investment Advisors fully exited Allergan plc in Q2 2020, selling an estimated $18.9M.
  • Nisa Investment Advisors's ten largest holdings make up 22% of its $10.9B portfolio in Q2 2020.
  • Nisa Investment Advisors opened 88 new positions and closed 97 in Q2 2020.
  • Nisa Investment Advisors's portfolio value rose 21% quarter-over-quarter to $10.9B.

Based on Nisa Investment Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.